Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q77291795)
Watch
English
Standard and low-dose chemotherapy for the treatment of myelodysplastic syndromes
scientific article published on 01 May 1998
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9734695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734695%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Standard and low-dose chemotherapy for the treatment of myelodysplastic syndromes
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9734695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734695%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
author
Bruce D. Cheson
series ordinal
1
object named as
B D Cheson
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9734695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734695%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
publication date
1 May 1998
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9734695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734695%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
published in
Leukemia Research
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9734695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734695%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
volume
22 Suppl 1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9734695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734695%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
page(s)
S17-21
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9734695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734695%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
cites work
A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Differentiation of myeloid leukaemic cells: new possibilities for therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low dose arabinosyl cytosine for treatment of myelodysplastic syndromes and subacute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of preleukemic syndromes with continuous intravenous infusion of low-dose cytosine arabinoside.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A therapeutic trial with low-dose cytarabine in myelodysplastic syndromes and acute leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low dose cytosine arabinoside (Ara C) in myelodysplastic syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low dose cytarabine in acute non-lymphoblastic leukemia or myelodysplastic syndrome: report of six cases and review of the literature
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Response of preleukemic syndromes to continuous infusion of low-dose cytarabine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Myelodysplastic syndrome treatment with danazol and cis-retinoic acid
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of low-dose cytosine arabinoside and aggressive chemotherapy in advanced myelodysplastic syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Refractory anemia with excess of blast cells: prognostic factors and effect of treatment with androgens or cytosine arabinoside. Results of a prospective trial in 58 patients. Cooperative Group for the Study of Aplastic and Refractory Anemias
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of myelodysplastic syndrome and atypical leukemia with low-dose aclarubicin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cephalotaxine esters: antileukemic advance or therapeutic failure?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
5-azacytidine in acute leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of schedule on activity and toxicity of 5-azacytidine in acute leukemia: A southwest oncology group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Response to 5-azacytidine in patients with refractory acute nonlymphocytic leukemia and association with chromosome findings
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of continuous infusion low-dose 5-azacytidine in the treatment of myelodysplastic syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Complete hematologic remission with oral etoposide in a patient with chronic myelomonocytic leukemia and profound dyserythropoiesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of chronic myelomonocytic leukemia with low dose etoposide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II clinical trial of carboplatin infusion in high-risk acute nonlymphoblastic leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I study of a new cisplatin derivative for hematologic malignancies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Infusion carboplatin treatment of relapsed and refractory acute leukemia: evidence of efficacy with minimal extramedullary toxicity at intermediate doses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of myelodysplastic syndromes with low-dose oral 6-thioguanine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900039-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0145-2126(98)00039-3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9734695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734695%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
PubMed publication ID
9734695
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9734695
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734695%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
